Abound Wealth Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
Abound Wealth Management's TGTX Position: Q3 2026 in Review
Abound Wealth Management held its TG Therapeutics (TGTX) position steady in Q3 2026 at 3,506 shares worth $196K. The position accounts for 0.04% of the portfolio, ranked #115.
Abound Wealth Management first reported a position in TGTX in Q3 2024 and has held it in 9 quarters since. 451 funds tracked by Wall St. Rank hold TGTX as of Q3 2026.
- Abound Wealth Management held 3,506 shares of TG Therapeutics worth $196K as of Q3 2026.
- Abound Wealth Management left its TG Therapeutics share count unchanged in Q3 2026.
- TG Therapeutics made up 0.04% of Abound Wealth Management's portfolio in Q3 2026, its #115 holding.
- Abound Wealth Management first reported a position in TG Therapeutics in Q3 2024 and has held it in 9 quarters since.
- 451 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2026.
Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.